Skip to content

Enhancing Smoking Cessation in the Homeless Population

Enhancing Smoking Cessation in the Homeless Population

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01932996
Enrollment
352
Registered
2013-08-30
Start date
2015-01-31
Completion date
2018-10-31
Last updated
2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking, Smoking, Tobacco, Tobacco Smoking

Keywords

Smoking Cessation, Smoking Cessation Products, Tobacco Use Cessation Products

Brief summary

The goal of this research study is to enhance smoking cessation rates for homeless smokers. The original study design proposed to test the effects of 1) an Intensive Smoking Intervention, and 2) integrating alcohol abuse treatment with smoking cessation We will utilize a 3-group randomized design to test study hypotheses. The three study conditions are 1) Integrated Intensive Smoking plus Alcohol intervention using cognitive behavioral therapy (CBT), CBT-(IS+A); 2) Intensive Smoking Intervention using CBT-(IS); or 3) Usual Care (brief smoking cessation and brief alcohol counseling both based on the United States Public Health Service's Guidelines)-(UC). Due to low enrollment because of the addition of an alcohol use screening criteria, the study was changed to a two arm study and the study time frame changed. The two study conditions are 1) Integrated Intensive Smoking plus Alcohol intervention using cognitive behavioral therapy (CBT), CBT-(IS+A) and 2) Usual Care (brief smoking cessation and brief alcohol counseling both based on the United States Public Health Service's Guidelines)-(UC). The study length is reduced to 26 weeks from 52 weeks. All participants will receive 12-week treatment with nicotine patch plus nicotine gum/lozenge. Counseling will follows the protocol used in a recent study of alcohol dependent smokers and will include weekly individual sessions for 3 months followed by study data collection visits 3 months. Both study conditions will have equal number of study contacts. Study staff will make retention contacts with participants in the community during weeks that do not have study visits scheduled. Primary smoking outcome is cotinine-verified 7-day smoking abstinence at week 26 follow-up while secondary outcome is prolonged smoking abstinence at weeks 12, 16, and 26. Secondary alcohol outcome will be self-reported continuous alcohol abstinence for 90 days at week 26. Recruitment and retention will be enhanced by use of gift cards, bus passes, other non-monetary incentives, attractive intervention materials, collaboration with homeless shelters, and advice from a Community Advisory Board. Participants will be enrolled from homeless shelters and facilities in the 7-county greater Minneapolis/St. Paul metro area. Our power calculation indicates that a sample size of 215 per study condition is needed to detect proposed treatment effects.

Detailed description

To achieve the study goal, we have selected a 3-group randomized clinical trial (RCT) design that includes 1) Usual Care, 2) Intensive smoking cessation, and 3) Integrated Intensive Smoking and Alcohol Intervention. Due to low enrollment because of the addition of an alcohol use screening criteria, the study was changed to a two arm study and the study time frame changed. The two study conditions are 1) Integrated Intensive Smoking plus Alcohol intervention using cognitive behavioral therapy (CBT), CBT-(IS+A) and 2) Usual Care (brief smoking cessation and brief alcohol counseling both based on the United States Public Health Service's Guidelines)-(UC). The study length is reduced to 26 weeks from 52 weeks. Having alcohol treatment added to the smoking intervention will enable us assess whether addressing alcohol abuse will result in improved smoking abstinence, an important scientific question that has never been studied in homeless populations. Study conditions: Both study conditions have identical number of contacts; we considered a design in which the duration of counseling in the UC will be identical to those in the IS+A condition but decided against this because it will create a usual care condition that exceeds standard practice for brief interventions. We understand that testing hypothesis 3 confounds contact time with treatment content, and hence we will not be able to determine that observed differences in outcome are due to specific treatment components. However, given the current state of knowledge about treating homeless alcohol abusing smokers, we believe it is sufficient to show that our intervention led to improved outcome in this group without knowing if the finding is due to specific intervention content. Subsequent research will be needed to disentangle various intervention components. All participants will receive 12-week treatment with nicotine patch plus nicotine gum/lozenge. Counseling will include weekly individual sessions for 3 months followed by study data collection visits for 3 months. Each participant will be randomly assigned to a condition, which will dictate their treatment. Each participant will be asked to engage in the therapy assigned to their condition, and work to quit smoking and consuming alcohol over a period of one year.

Interventions

DRUGnicotine patch plus nicotine gum/lozenge

12-week treatment with nicotine patch plus nicotine gum/lozenge

BEHAVIORALIntensive Alcohol Intervention

Intensive alcohol abstinence counseling using CBT will include weekly individual sessions for 3 months followed by monthly booster group sessions for 3 months

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Currently Homeless * Smoked at least 100 cigarettes in lifetime * AUDIT score of \> or equal to 5, \< or equal to 26 * Aged 18 years or older * Willing to attend study sessions and follow other study protocol

Exclusion criteria

* Use of smoking cessation medications or interventions in last 30 days * Unstable medical illness that requires immediate medical care * AUDIT score of \< 5 or \> 26 * Pregnancy or other Nicotine Replacement Therapy (NRT) contraindications * Current history or in past 6 months of psychotic disorder or major depressive disorders that is not stable on treatment for past 3 months * Cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
CO-verified Smoking Status at 26 Weeks7-day smoking abstinence at week 26 follow-upSmoking status is verified by measuring the concentration of carbon monoxide (CO) in expired air. Participants with a breath CO content less than or equal to 8 parts per million are characterized as abstinent from smoking for at least 7 days.

Secondary

MeasureTime frameDescription
CO-verified Smoking Status at 12 Weeksat weeks 12Smoking status is verified by measuring the concentration of carbon monoxide (CO) in expired air. Participants with a breath CO content less than or equal to 8 parts per million are characterized as abstinent from smoking for at least 7 days.

Other

MeasureTime frameDescription
Self-Reported Continuous Alcohol Abstinence for 30 Daysat week 26Participants will use a self-administered timeline-followback instrument, which asks them to retrospectively estimate their alcohol use in the 30 days prior to the report date. Outcome is reported as the mean number of continuous alcohol-free days over the past 30 day period.

Countries

United States

Participant flow

Participants by arm

ArmCount
Integrated Intensive Smoking + Alcohol
IS+A: 12-week treatment with nicotine patch plus nicotine gum/lozenge. An integrated intensive smoking along with an intensive alcohol intervention covering smoking cessation + alcohol abstinence using cognitive behavioral therapy, CBT, and will include weekly individual sessions for 3 months followed by study data collection visits for 3 months. nicotine patch plus nicotine gum/lozenge: 12-week treatment with nicotine patch plus nicotine gum/lozenge Intensive Alcohol Intervention: Intensive alcohol abstinence counseling using CBT will include weekly individual sessions for 3 months followed by monthly booster group sessions for 3 months
172
Usual Care
UC: 12-week treatment with nicotine patch plus nicotine gum/lozenge along with a one time brief smoking cessation and brief alcohol counseling both based on the USPHS's Guidelines nicotine patch plus nicotine gum/lozenge: 12-week treatment with nicotine patch plus nicotine gum/lozenge
180
Total352

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation20

Baseline characteristics

CharacteristicIntegrated Intensive Smoking + AlcoholUsual CareTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants5 Participants10 Participants
Age, Categorical
Between 18 and 65 years
167 Participants175 Participants342 Participants
Age, Continuous46 years
STANDARD_DEVIATION 10.6
46 years
STANDARD_DEVIATION 11.3
46 years
STANDARD_DEVIATION 11.6
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants5 Participants6 Participants
Race (NIH/OMB)
Asian
0 Participants3 Participants3 Participants
Race (NIH/OMB)
Black or African American
127 Participants123 Participants250 Participants
Race (NIH/OMB)
More than one race
8 Participants14 Participants22 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
8 Participants3 Participants11 Participants
Race (NIH/OMB)
White
28 Participants32 Participants60 Participants
Sex: Female, Male
Female
28 Participants48 Participants76 Participants
Sex: Female, Male
Male
144 Participants132 Participants276 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1721 / 180
other
Total, other adverse events
90 / 172101 / 180
serious
Total, serious adverse events
0 / 1720 / 180

Outcome results

Primary

CO-verified Smoking Status at 26 Weeks

Smoking status is verified by measuring the concentration of carbon monoxide (CO) in expired air. Participants with a breath CO content less than or equal to 8 parts per million are characterized as abstinent from smoking for at least 7 days.

Time frame: 7-day smoking abstinence at week 26 follow-up

ArmMeasureValue (NUMBER)
Integrated Intensive Smoking + AlcoholCO-verified Smoking Status at 26 Weeks16.3 percentage of participants
Usual CareCO-verified Smoking Status at 26 Weeks12.6 percentage of participants
Secondary

CO-verified Smoking Status at 12 Weeks

Smoking status is verified by measuring the concentration of carbon monoxide (CO) in expired air. Participants with a breath CO content less than or equal to 8 parts per million are characterized as abstinent from smoking for at least 7 days.

Time frame: at weeks 12

ArmMeasureValue (NUMBER)
Integrated Intensive Smoking + AlcoholCO-verified Smoking Status at 12 Weeks21.6 percentage of participants
Usual CareCO-verified Smoking Status at 12 Weeks14 percentage of participants
Other Pre-specified

Self-Reported Continuous Alcohol Abstinence for 30 Days

Participants will use a self-administered timeline-followback instrument, which asks them to retrospectively estimate their alcohol use in the 30 days prior to the report date. Outcome is reported as the mean number of continuous alcohol-free days over the past 30 day period.

Time frame: at week 26

ArmMeasureValue (MEAN)Dispersion
Integrated Intensive Smoking + AlcoholSelf-Reported Continuous Alcohol Abstinence for 30 Days3.4 daysStandard Deviation 0.71
Usual CareSelf-Reported Continuous Alcohol Abstinence for 30 Days3.9 daysStandard Deviation 0.71

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026